scholarly journals Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries

2014 ◽  
Vol 17 (7) ◽  
pp. A364 ◽  
Author(s):  
V. Brodszky ◽  
L. Gulacsi ◽  
O. Balogh ◽  
P Baji ◽  
F. Rencz ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
European Countries ◽  
Eastern European ◽  
Central Eastern ◽  
Eastern European Countries

scholarly journals Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn’s disease using real world evidence in Thailand

2020 ◽  
Vol 23 (11) ◽  
pp. 1302-1310
Author(s):  
Pochamana Phisalprapa ◽  
Chayanis Kositamongkol ◽  
Julajak Limsrivilai ◽  
Satimai Aniwan ◽  
Phunchai Charatcharoenwitthaya ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Cost Effectiveness ◽  
Crohn's Disease ◽  
Real World ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Real World Evidence
Sign in / Sign up

Export Citation Format

Share Document